Next |
home / stock / okyo / okyo message board
Subject | By | Source | When |
---|---|---|---|
Big volume, just needed to take a breathe | mfayman | investorshub | 10/05/2023 3:53:59 PM |
Will end up green today | Sirpeter | investorshub | 10/05/2023 3:26:10 PM |
Will be over $3 by Monday... | Sirpeter | investorshub | 10/05/2023 2:24:52 PM |
Got to add down here...could be a $75-100 | Sirpeter | investorshub | 10/05/2023 2:09:11 PM |
..thought it make $3..sell the news, terrible.. $OKYO$... | Pisd | investorshub | 10/05/2023 2:04:57 PM |
Got some $2.35s...deal | Sirpeter | investorshub | 10/05/2023 1:57:25 PM |
Bought more this morning...luv sales | Sirpeter | investorshub | 10/05/2023 1:39:37 PM |
https://ih.advfn.com/stock-market/NASDAQ/okyo-pharma-$OKYO/stock-news/92205380/fo | Pisd | investorshub | 10/05/2023 12:40:14 PM |
Looks like we're seeing it $$ been a | mfayman | investorshub | 10/05/2023 12:05:24 PM |
$OKYO Pharma Announces Positive Safety Data Profile for | Ryguy008 | investorshub | 10/05/2023 11:42:22 AM |
Up to 3.5$ pre market this morning let's | mfayman | investorshub | 10/05/2023 11:22:46 AM |
3$+ is the next stop | mfayman | investorshub | 10/05/2023 11:02:06 AM |
Nice little ore market action | mfayman | investorshub | 10/05/2023 11:01:34 AM |
$OKYO Video - Corporate Profile on $OKYO Pharma | Count Crypto | investorshub | 10/05/2023 9:31:12 AM |
Excellent close!! Once 2.50 broke that was it | mfayman | investorshub | 10/04/2023 10:25:39 PM |
Have a look at this | mfayman | investorshub | 10/04/2023 8:42:10 PM |
MomentumIts trading up | Ryguy008 | investorshub | 10/04/2023 8:24:22 PM |
https://news.squeezereport.com/short-squeeze/okyo-pharma-limited-nasdaq-okyo-sho | Count Crypto | investorshub | 10/04/2023 7:53:42 PM |
$OKYO Anyone hear anything lately? Want to see this one go | Count Crypto | investorshub | 10/04/2023 7:43:55 PM |
Loaded | Count Crypto | investorshub | 10/04/2023 7:40:35 PM |
News, Short Squeeze, Breakout and More Instantly...
LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases...
ORLANDO, FL / ACCESSWIRE / August 23, 2024 / RedChip Companies will air interviews with OKYO Pharma Ltd. (Nasdaq:OKYO) and SolarMax Technology, Inc. (Nasdaq:SMXT) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 24, at 7 p.m. Easte...
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases...